SRP
GILD icon

Saddle Road Partners’s Gilead Sciences GILD Stock Holding History

Saddle Road Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.31M Buy
18,299
+2,985
+19% +$222K 0.67% 36
2016
Q3 		$1.21M Buy
15,314
+1,203
+9% +$97.7K 0.69% 37
2016
Q2 		$1.18M Hold
14,111
– – 0.71% 38
2016
Q1 		$1.3M Buy
14,111
+549
+4% +$49.5K 0.82% 38
2015
Q4 		$1.37M Buy
+13,562
New +$1.41M 0.94% 36

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Saddle Road Partners's GILD Position: Q4 2016 in Review

Saddle Road Partners increased its Gilead Sciences (GILD) stake by 19% in Q4 2016, buying an estimated $222K and bringing the position to 18,299 shares worth $1.31M. The position accounts for 0.67% of the portfolio, ranked #36.

Saddle Road Partners first reported a position in GILD in Q4 2015 and has held it in 5 quarters since. The position peaked at $1.37M in Q4 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Saddle Road Partners held 18,299 shares of Gilead Sciences worth $1.31M as of Q4 2016.
  • Saddle Road Partners bought 2,985 Gilead Sciences shares in Q4 2016, an estimated $222K.
  • Gilead Sciences made up 0.67% of Saddle Road Partners's portfolio in Q4 2016, its #36 holding.
  • Saddle Road Partners first reported a position in Gilead Sciences in Q4 2015 and has held it in 5 quarters since.
  • Saddle Road Partners's Gilead Sciences position peaked at $1.37M in Q4 2015.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Saddle Road Partners's 13F filing for Q4 2016, filed 6 Jan 2017.